表紙
市場調查報告書

躁鬱症治療藥的全球市場

Bipolar Disorder

出版商 Global Industry Analysts, Inc. 商品編碼 912724
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
躁鬱症治療藥的全球市場 Bipolar Disorder
出版日期: 2019年10月01日內容資訊: 英文 156 Pages
簡介

本報告提供全球躁鬱症治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球躁鬱症治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 日本
    • 加拿大
    • 中國
    • 法國
    • 歐洲
    • 義大利
    • 德國
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBVIE
  • ALLERGAN PLC
  • ASTRAZENECA PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • JANSSEN PHARMACEUTICA NV
  • NOVARTIS INTERNATIONAL AG
  • 大塚製藥
  • PFIZER

第5章 調查資料

目錄
Product Code: MCP-6202

Bipolar Disorder market worldwide is projected to grow by US$848.8 Million, driven by a compounded growth of 2.3%. Mood Stabilizers, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$608.5 Million by the year 2025, Mood Stabilizers will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$34 Million to the region's size and clout in the next 5 to 6 years. Over US$24.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Mood Stabilizers will reach a market size of US$28.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$231.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AbbVie, Inc.; Allergan PLC; AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Janssen Pharmaceuticals; Novartis International AG; Otsuka Pharmaceutical Co., Ltd.; Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Bipolar Disorder Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Bipolar Disorder Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Bipolar Disorder Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Bipolar Disorder Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Mood Stabilizers (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Mood Stabilizers (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Mood Stabilizers (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Anticonvulsants (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Anticonvulsants (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Anticonvulsants (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Antipsychotic Drugs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Antipsychotic Drugs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Antipsychotic Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Antidepressant Drugs (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Antidepressant Drugs (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Antidepressant Drugs (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Anti-anxiety Drugs (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Anti-anxiety Drugs (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Anti-anxiety Drugs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Bipolar Disorder Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 20: Bipolar Disorder Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 21: United States Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 22: Japanese Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 23: Bipolar Disorder Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 24: Japanese Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 26: Canadian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 27: Bipolar Disorder Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • CHINA
    • TABLE 28: Chinese Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 29: Bipolar Disorder Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 30: Chinese Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • FRANCE
    • TABLE 31: Bipolar Disorder Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 32: French Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 33: French Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Bipolar Disorder Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 34: European Bipolar Disorder Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 35: Bipolar Disorder Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 36: European Bipolar Disorder Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 38: Bipolar Disorder Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 39: European Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 40: Italian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 41: Bipolar Disorder Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 42: Italian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • GERMANY
    • TABLE 43: Bipolar Disorder Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 44: German Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 45: German Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 47: Bipolar Disorder Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 48: United Kingdom Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 49: Spanish Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 50: Spanish Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 51: Bipolar Disorder Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 52: Russian Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 53: Bipolar Disorder Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 54: Russian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 56: Bipolar Disorder Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 57: Rest of Europe Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 59: Bipolar Disorder Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 60: Asia-Pacific Bipolar Disorder Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 61: Bipolar Disorder Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: Asia-Pacific Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 63: Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 64: Bipolar Disorder Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 65: Australian Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 66: Australian Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 67: Indian Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 68: Indian Bipolar Disorder Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 69: Bipolar Disorder Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 70: Bipolar Disorder Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 71: South Korean Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 72: Bipolar Disorder Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 74: Bipolar Disorder Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 75: Rest of Asia-Pacific Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 76: Latin American Bipolar Disorder Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 77: Bipolar Disorder Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 78: Latin American Bipolar Disorder Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 79: Latin American Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 80: Bipolar Disorder Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 81: Latin American Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 82: Argentinean Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 83: Bipolar Disorder Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 84: Argentinean Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 85: Bipolar Disorder Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 86: Brazilian Bipolar Disorder Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 87: Brazilian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 88: Bipolar Disorder Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 89: Mexican Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 90: Mexican Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 92: Bipolar Disorder Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 93: Rest of Latin America Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 94: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 95: Bipolar Disorder Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 96: The Middle East Bipolar Disorder Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 97: The Middle East Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 98: The Middle East Bipolar Disorder Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 99: Bipolar Disorder Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 100: Iranian Market for Bipolar Disorder: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 101: Bipolar Disorder Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 102: Iranian Bipolar Disorder Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 103: Israeli Bipolar Disorder Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 104: Bipolar Disorder Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 105: Israeli Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabian Bipolar Disorder Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 107: Bipolar Disorder Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 108: Saudi Arabian Bipolar Disorder Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 109: Bipolar Disorder Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 110: United Arab Emirates Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 111: Bipolar Disorder Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 112: Bipolar Disorder Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 113: Rest of Middle East Bipolar Disorder Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 114: Rest of Middle East Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 115: African Bipolar Disorder Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 116: Bipolar Disorder Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 117: African Bipolar Disorder Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBVIE
  • ALLERGAN PLC
  • ASTRAZENECA PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • JANSSEN PHARMACEUTICA NV
  • NOVARTIS INTERNATIONAL AG
  • OTSUKA PHARMACEUTICAL
  • PFIZER

V. CURATED RESEARCH

Back to Top